Tiago Fauth

Stock Analyst at Wells Fargo

(0)
# 4700
Out of 5,328 analysts
165
Total ratings
29.25%
Success rate
-21.25%
Average return
44 Stocks
Name Action PT Current % Upside Ratings Updated
VRNA Verona Pharma
Maintains: Overweight
93 107
72.16 48.28% 5 Apr 30, 2025
UTHR United Therapeutics
Downgrades: Equal-Weight
395 314
293.04 7.15% 5 Apr 25, 2025
TECX Tectonic Therapeutic
Maintains: Overweight
112 101
19.91 407.28% 4 Mar 21, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Equal-Weight
275 287
252.64 13.6% 5 Mar 21, 2025
PLRX Pliant Therapeutics
Maintains: Equal-Weight
4 3
1.62 85.19% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 26
14.39 80.68% 6 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 17
6.66 155.26% 1 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
85 107
72.8 46.98% 3 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 11
1.18 832.2% 2 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 88
38.97 125.81% 7 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
8
3.27 144.65% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.96 81.45% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
56 68
49.26 38.04% 1 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 22
7.96 176.38% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
75
49.52 51.45% 1 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
1225 70
2.68 2511.94% 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 62
1.38 4392.75% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
89
166.36 -46.5% 16 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
51
13.76 270.64% 3 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
120
62.88 90.84% 7 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
120
n/a n/a 6 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
4
16.14 -75.22% 4 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 17
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
3.03 362.05% 4 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.08 4900% 5 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
26
6.46 302.48% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 28
2.51 1015.54% 7 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 81
20.33 298.43% 11 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
139 200
n/a n/a 5 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
1
n/a n/a 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8
0.5 1500% 5 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
1.1 1172.73% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 34
0.52 6438.46% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
150
3.03 4850.5% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
29
38.95 -25.55% 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
1.74 647.13% 1 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 13
1.6 712.5% 2 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
n/a n/a 3 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
3 2
1.78 12.36% 4 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
297 340
643.16 -47.14% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 18
n/a n/a 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 98
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
265 259
284.76 -9.05% 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 42
n/a n/a 5 Nov 10, 2020